liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Riboflavin-UV-A Crosslinking for Fixation of Biosynthetic Corneal Collagen Implants
Technical University of Munich, Germany.
Technical University of Munich, Germany.
Technical University of Munich, Germany.
Technical University of Munich, Germany.
Show others and affiliations
2015 (English)In: Cornea, ISSN 0277-3740, E-ISSN 1536-4798, Vol. 34, no 5, 544-549 p.Article in journal (Refereed) Published
Abstract [en]

Purpose: To evaluate riboflavin-UV-A crosslinking as an alternative suture-free fixation method for biosynthetic corneal collagen implants. Methods: A range of cell-free corneal implants consisting of recombinant human collagen type III were examined. In vitro, the implants were crosslinked with different riboflavin solutions and irradiations. Ex vivo, the biosynthetic corneal implants were placed on the anterior cornea of porcine and rabbit eyes after performing deep anterior lamellar keratoplasty with a trephine, femtosecond laser, or excimer laser. UV-A crosslinking was performed with isotonic or hypotonic riboflavin at either standard or rapid procedure. The corneas were excised, fixed in PFA 4%, and embedded in paraffin. Crosslinking effects on the implants and the adhesion between implant and corneal bed were evaluated by slit-lamp biomicroscopy, optical coherence tomography (OCT) images, and histologically. Results: After the crosslinking procedure, the implants showed different degrees of thinning. The accuracy of cutting the corneal bed was highest with the excimer laser. Good adhesion of the implant in the corneal bed could be demonstrated in OCT images. This was more accurate in porcine eyes than in rabbit eyes. Histologically, crosslinks between implant and corneal stroma were demonstrated. There was no difference between standard and rapid crosslinking procedures. Conclusions: Riboflavin-UV-A crosslinking as a fixation method for biosynthetic corneal collagen implants was demonstrated to be promising. It can reduce suture-related complications such as haze formation and surface irregularity. Stability of the implants, especially shrinkage after riboflavin-UV-A crosslinking, needs to be further evaluated. Biostability, integration, and long-term outcome are further evaluated in in vivo animal experiments.

Place, publisher, year, edition, pages
LIPPINCOTT WILLIAMS and WILKINS , 2015. Vol. 34, no 5, 544-549 p.
Keyword [en]
collagen implant; riboflavin-UV-A crosslinking; biosynthetic cornea; laser DALK; corneal transplantation; keratoprosthesis
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-117641DOI: 10.1097/ICO.0000000000000399ISI: 000352208800019PubMedID: 25768385OAI: oai:DiVA.org:liu-117641DiVA: diva2:811569
Note

Funding Agencies|EU nanomedicine ERA-net project I-CARE; VDI (Verein Deutscher Ingenieure); VDO

Available from: 2015-05-12 Created: 2015-05-06 Last updated: 2015-05-26

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Griffith, May
By organisation
Division of Cell BiologyFaculty of Health Sciences
In the same journal
Cornea
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 101 hits
ReferencesLink to record
Permanent link

Direct link